Michael F. Huang - Sr. VP of Clinical Development at SOLENO THERAPEUTICS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Sr. VP of Clinical Development
Issuer Symbol
SLNO on Nasdaq
All Insider Reports
All Insider Reports

Michael F. Huang - trading volume in the past year for SOLENO THERAPEUTICS INC

Holdings reported by Michael F. Huang for SOLENO THERAPEUTICS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 46,405 $2,148,514 $46.30 21 Jan 2026 Direct
Employee stock option (right to buy) 11,900 21 Jan 2026 Direct Common Stock

Transactions reported by Michael F. Huang for SOLENO THERAPEUTICS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.